InvestSMART

Proteomics International Laboratories Ltd (ASX: PIQ) - Announcements

Current share price for PIQ : $0.125 0.015 (10.71%)+

ASX company news and announcements for Proteomics International Laboratories Ltd (PIQ) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Proteomics International Laboratories Ltd (PIQ) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Proteomics International Laboratories Ltd (PIQ), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Proteomics International Laboratories Ltd (PIQ)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$21 Ignite Investment Summit Presentation 14 Oct 2026 8:41AM $0.140 $0.125 fallen by 10.71%
$21 PromarkerEndo Validation and Refinement Complete 13 Oct 2026 8:43AM $0.130 $0.125 fallen by 3.85%
$21 Notice of AGM Date 24 Sep 2026 2:53PM $0.120 $0.125 risen by 4.17%
$21 Investor Presentation 23 Sep 2026 9:58AM $0.135 $0.125 fallen by 7.41%
$21 PromarkerD and PromarkerEso Commercial Rollout Update 14 Sep 2026 9:47AM $0.140 $0.125 fallen by 10.71%
$21 Appendix 4E and Annual Report 31 Aug 2026 4:35PM $0.150 $0.125 fallen by 16.67%
$21 Appendix 4G and Corporate Governance Statement 31 Aug 2026 4:32PM $0.150 $0.125 fallen by 16.67%
$21 Australian patent for PromarkerEndo 13 Aug 2026 8:46AM $0.155 $0.125 fallen by 19.35%
$21 Change in substantial holding 5 Aug 2026 8:17AM $0.140 $0.125 fallen by 10.71%
$21 Quarterly Activities/Appendix 4C Cash Flow Report 27 Jul 2026 9:48AM $0.155 $0.125 fallen by 19.35%
$21 Webinar Presentation - Healius distribution agreement 23 Jul 2026 9:29AM $0.185 $0.125 fallen by 32.43%
$21 Proteomics signs national distribution deal with Healius 22 Jul 2026 8:30AM $0.150 $0.125 fallen by 16.67%
$21 Application for quotation of securities - PIQ 13 Jul 2026 8:24AM $0.205 $0.125 fallen by 39.02%
$21 US patent secured for PromarkerEndo 8 Jul 2026 10:09AM $0.160 $0.125 fallen by 21.88%
$21 Notification of cessation of securities - PIQ 7 Jul 2026 9:07AM $0.175 $0.125 fallen by 28.57%
$21 Response to ASX Price Query 3 Jul 2026 5:28PM $0.200 $0.125 fallen by 37.50%
$21 Change of Registered Office Address 2 Jul 2026 11:52AM $0.143 $0.125 fallen by 12.28%
$21 Application for Quotation of Securities - PIQ 3 Jun 2026 9:59AM $0.140 $0.125 fallen by 10.71%
$21 Response to ASX Price Query 7 May 2026 1:18PM $0.185 $0.125 fallen by 32.43%
$21 Notification of Expiry of Listed Options - PIQO 1 May 2026 10:07AM $0.235 $0.125 fallen by 46.81%
$21 Quarterly Activities/Appendix 4C Cash Flow Report 28 Apr 2026 9:13AM $0.265 $0.125 fallen by 52.83%
$21 Proteomics Strategic Plan 28 Apr 2026 8:59AM $0.265 $0.125 fallen by 52.83%
$21 Final Director's Interest Notice 17 Apr 2026 2:37PM $0.260 $0.125 fallen by 51.92%
$21 Restructure, Executive Appointment and Board Update 17 Apr 2026 9:21AM $0.250 $0.125 fallen by 50%
$21 Appendix 4D and Interim Financial Report 25 Feb 2026 8:43AM $0.355 $0.125 fallen by 64.79%

1 - 25 of 698 results

Page 1 of 28

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.